Syncope Due to Torsade De Pointes in an HIV-Infected Patient Receiving Methadone Treatment

Syncope Cases

Volumn , Issue , 2007, Pages 165-167

  Anguera, I ^a   Gil, M ^a   Sala, M ^a   Chapinal, O ^a   Cervantes, M ^a   Guma J R ^a   Segura, F ^a   Rubio, A Martínez ^a  

^a HOSPITAL DE SABADELL   (Spain)

Author keywords

Electrocardiogram (ECG); HIV infected patient; Methadone; Syncope; Torsade de pointes

Indexed keywords

EID: 84889287131     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470995013.ch57     Document Type: Chapter

References (6)

1. De Ponti F, Poluzzi E. Organising evidence of QT prolongation and occurrence of torsades de pointes with non-antiarrhythmic drugs: a call for consensus. Eur J Clin Pharmacol 2001; 57: 185-209.
2. Mantelli L, Corti V, Bini R, Cerbai E, Ledda F. Effect of dl-methadone on the response to physiological transmitters and on several functional parameters of the isolated guinea-pig heart. Arch Int Pharmacodyn Ther 1986; 282: 298-313.
3. Lipski J, Stimmel B, Donoso E. The effect of heroin and multiple drug abuse on the electrocardiogram. Am Heart J 1973; 86: 663-8.
4. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler P. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 2002; 137: 501-4.
5. Kocheril AG, Bokhari SA, Batsford WP, Sinisas AJ. Long QTc and torsades de pointes in human immunodeficiency virus disease. Pacing Clin Electrophysiol 1997; 20: 2810-6.
6. Villa A, Foresti V, Confalonieri F. Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin Auton Res 1995; 5: 48-52.